首页 › 多发性骨髓瘤 › 密歇根州 › Ann Arbor
Ann Arbor MI 多发性骨髓瘤临床试验
13项针对 多发性骨髓瘤的研究正在 Ann Arbor及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
招募中3 期
- University of Michigan, Ann Arbor
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
招募中3 期
- University of Michigan Rogel Cancer Center, Ann Arbor
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
招募中2 期
- University of Michigan Health System, Ann Arbor
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
招募中2 期
- University of Michigan, Ann Arbor
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
招募中1/2 期
- Research Site, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
招募中1/2 期
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- University of Michigan, Ann Arbor
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
招募中1/2 期
- Research Site, Ann Arbor
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- Trinity Health Ann Arbor Hospital, Ann Arbor
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
招募中3 期
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 距离 7 英里
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距离 7 英里
- 以及另外 4 项
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
招募中4 期
- University of Michigan, Ann Arbor
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
招募中3 期
- Saint Joseph Mercy Hospital, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 距离 7 英里
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 距离 7 英里
- 以及另外 4 项
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
招募中3 期
- GSK Investigational Site, Ann Arbor
其他城市的 多发性骨髓瘤试验
- New York City, NY59 项研究
- Boston, MA45 项研究
- Atlanta, GA42 项研究
- Houston, TX39 项研究
- Durham, NC36 项研究
- Nashville, TN31 项研究
- Denver, CO26 项研究
- St. Louis, MO26 项研究
- Rochester, MN25 项研究
- Columbus, OH25 项研究
- Chicago, IL24 项研究
- Milwaukee, WI23 项研究
Ann Arbor的其他研究
- 前列腺癌26 项研究
- 癌症（所有类型）25 项研究
- 乳腺癌25 项研究
- 肺癌23 项研究
- 非小细胞肺癌23 项研究
- 结直肠癌22 项研究
- 心力衰竭21 项研究
- 急性髓系白血病17 项研究
- 心血管疾病15 项研究
- 胰腺癌14 项研究
- 心房颤动12 项研究
- 卵巢癌12 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。